动物肠道健康市场按产品类型、动物类型、应用、配方和分销管道划分－2025-2032年全球预测

预计到 2032 年，动物肠道健康市场规模将成长 67.8 亿美元，复合年增长率为 5.95%。

以微生物组科学为指导的策略实施，将肠道健康置于整个畜牧生产系统商业性和永续性的核心地位。

动物肠道健康已从一种小众营养补充品发展成为畜牧业、水产养殖业和伴侣动物生产系统的核心支柱。微生物组科学的进步使人们重新认识到，肠道健康是一个多因素共同作用的结果，受饲料配方、标靶生物活性、宿主免疫力和管理措施等因素的影响。因此，生产者和价值链上的相关人员越来越重视优化肠道功能的干预措施，并将其置于提高动物适应能力、资源利用效率和动物福利策略的核心位置。

同时，监管机构正逐步减少对关键抗生素的使用，转而采用基于实证医学的替代疗法，这推动了对精准饲料添加剂和标靶营养策略的需求。这项转变伴随着产品传输、诊断监测和数据主导决策等方面的技术整合。综上所述，这些新兴机会意味着肠道健康不再只是一项独立的技术考量，而是影响动物种类和生产系统盈利、永续性和市场差异化的策略槓桿。

科学突破、监管压力和数位化物流的融合如何加速动物肠道健康领域整体产品的创新和应用

过去五年，肠道健康领域发生了翻天覆地的变化，产品系列、供应链和消费者预期都发生了重塑。科学进步拓宽了有效干预措施的范围，使其从单一模式的解决方案发展到结合酶、有机酸、植物萃取物、益生元和益生菌以及性能诊断的综合疗法。这种整合得益于菌株鑑定技术的改进、提高稳定性的包埋技术以及针对不同物种和生命阶段特定生理需求而定制的颗粒剂配方。

此外，监管和市场压力正促使人们以实证替代方案取代频谱抗菌生长促进剂，从而刺激对临床试验、生物标记开发和农场检验研究的投资。除了产品创新之外，数位化和物流创新也实现了更精准的给药、可追溯性和快速的供应协调，缩短了从科学发现到商业性应用的时间。总而言之，这些转变正在创造一个更复杂但也充满机会的格局，研发、监管和商业团队之间的跨职能合作已成为竞争的必然要求。

评估2025年关税措施对动物肠道药物生态系中原料采购、配方决策与供应链韧性的影响

2025年新关税措施的实施，为依赖跨境原料流动和配方产品的相关人员带来了实质的贸易和成本复杂性。关税将影响进口酵素复合物、特殊有机酸和专有益生菌菌株的经济效益，迫使製造商和经销商重新评估筹资策略和库存政策。事实上，采购团队正在评估供应商多元化、本地製造伙伴关係以及后向整合，以在控製到岸成本的同时，维持供应的连续性。

此外，关税带来的价格讯号正在增强对国产原料和在地化配方的需求。因此，一些价值链参与者正在尽可能地加快配方简化，而另一些参与者则在投资原料替代研究和稳定性测试，以检验本地可用的替代品。这些措施正在影响下游产品差异化，能够展现检验性能和成本效益的高端解决方案正在获得竞争优势。同时，关税政策带来的监管审查正在推动采购和合规方面的透明度提高，进一步加重了小型供应商的行政负担，并给分销管道的整合带来了压力。

以细分市场为重点的洞察，揭示了产品类型、物种生理、应用、配方限制和分销策略如何决定产品开发路径。

深入的市场区隔分析揭示了不同产品类型、动物种类、应用、配方和分销管道的需求驱动因素和产品开发重点。按产品类型划分，市场研究涵盖酵素、有机酸、植物萃取物、益生元和益生菌。酵素进一步细分为植酸酶、蛋白酶和木聚醣酶，而益生菌则进一步细分为细菌益生菌和酵母益生菌。这种细分凸显了配方科学的重要性，即需要使触媒活性、pH耐受性和微生物相容性与目标饲料基质相匹配。依动物种类划分，市场研究涵盖水产养殖、伴侣动物、家禽、反刍动物和猪。水产养殖进一步细分为鱼虾；伴侣动物细分为猫狗；家禽细分为肉鸡、蛋鸡和火鸡；反刍动物细分为肉牛、乳牛、乳牛和山羊；猪细分为种猪、育肥猪以及母猪和仔猪。这些差异突显了物种和生命週期特异性的肠道生理，决定了不同的给药策略、载体系统和疗效的证据阈值。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 针对特定牲畜肠道菌丛量身订製的精准益生菌的应用日益增多
• 饲料核准审批监管的协调统一将推动动物肠道健康解决方案的成长。
• 为了改善断奶后仔猪的肠道健康，人们对饲料中添加抗生素替代品的需求日益增长。
• 利用次世代定序数据支持客製化动物微生物组干预
• 针对家禽肠道健康管理中发炎路径的后生元饲料添加剂的出现
• 将人工智慧应用于制定牲畜肠道健康精准营养策略

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按产品类型分類的动物肠道健康市场

• 酵素
  • 植酸酶
  • 蛋白酶
  • 木聚醣酶
• 有机酸
• 植物来源成分
• 益生元
• 益生菌
  • 细菌益生菌
  • 酵母益生菌

9. 依动物类型分類的动物肠道健康市场

• 水产养殖
  • 鱼
  • 虾
• 伴侣动物
  • 猫
  • 狗
• 家禽
  • 肉鸡
  • 产蛋母鸡
  • 火鸡
• 反刍动物
  • 肉牛
  • 乳牛
  • 绵羊和山羊
• 猪
  • 育种者
  • 发光定型剂
  • 母猪和小猪

第十章 动物肠道健康市场（依应用领域划分）

• 饲料添加剂
• 营养补充品
• 治疗

第十一章：按配方分類的动物肠道健康市场

• 液体
• 颗粒
• 粉末

第十二章：按分销管道分類的动物肠道保健市场

• 离线
  • 直销
  • 批发商
• 在线的

第十三章：按地区分類的动物肠道健康市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 按类别分類的动物肠道健康市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国动物肠道保健市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Koninklijke DSM NV
  • International Flavors & Fragrances Inc.
  • BASF SE
  • Evonik Industries AG
  • Kemin Industries, Inc.

The Animal Intestinal Health Market is projected to grow by USD 6.78 billion at a CAGR of 5.95% by 2032.

A strategic introduction that situates intestinal health as a core commercial and sustainability lever across animal production systems guided by microbiome science

The landscape of animal intestinal health has evolved from niche nutritional supplements to a central pillar of livestock, aquaculture, and companion animal production systems. Advances in microbiome science have reframed intestinal health as a multifactorial outcome driven by feed formulation, targeted bioactives, host immunity, and management practices. As a result, producers and value chain stakeholders are increasingly orienting strategy around interventions that optimize gut function to improve resilience, resource efficiency, and animal welfare.

Concurrently, regulatory momentum away from medically important antibiotics and toward evidence-based alternatives has elevated demand for precision feed additives and targeted nutritional strategies. This shift is accompanied by technological integration in product delivery, diagnostic monitoring, and data-driven decision-making. Collectively, these developments mean that intestinal health is no longer an isolated technical consideration but a strategic lever for profitability, sustainability, and market differentiation across species and production systems.

How converging scientific breakthroughs, regulatory pressure, and digital logistics are accelerating integrated product innovation and adoption across animal intestinal health

The past five years have witnessed transformative shifts that are reshaping product portfolios, supply chains, and buyer expectations in the intestinal health arena. Scientific advancements have broadened the palette of efficacious interventions beyond single-mode solutions to integrated regimens that combine enzymes, organic acids, phytogenics, prebiotics, and probiotics with performance diagnostics. This integration has been accelerated by improvements in strain characterization, encapsulation technologies that enhance stability, and granular formulations that match species- and life-stage-specific physiological needs.

In addition, regulatory and market pressures have incentivized the replacement of broad-spectrum antimicrobial growth promotants with evidence-based alternatives, catalyzing investment in clinical trials, biomarker development, and on-farm validation studies. Parallel to product innovation, digital and logistics innovations are enabling more precise dosing, traceability, and rapid-response supply adjustments, thereby reducing the time between scientific discovery and commercial adoption. Taken together, these shifts are creating a more complex but opportunity-rich landscape in which cross-functional collaboration between R&D, regulatory, and commercial teams becomes a competitive necessity.

Assessment of 2025 tariff impacts on ingredient sourcing, formulation decisions, and supply chain resilience within the animal intestinal health ecosystem

The introduction of new tariff measures in 2025 has introduced a tangible layer of trade and cost complexity for stakeholders who depend on cross-border ingredient flows and formulated products. Tariffs affect the economics of imported enzymatic complexes, specialty organic acids, and proprietary probiotic strains, prompting manufacturers and distributors to reassess sourcing strategies and inventory policies. In practice, this means procurement teams are increasingly evaluating supplier diversification, local manufacturing partnerships, and backward integration to maintain supply continuity while managing landed costs.

Moreover, tariff-induced price signals are reinforcing demand for domestically producible inputs and regionally tailored formulations. As a result, some value chain players are accelerating formulation simplification where feasible, while others are investing in ingredient substitution studies and stability testing to validate locally available alternatives. These dynamics have downstream implications for product differentiation, with premium solutions that demonstrate verifiable performance and cost-efficiency gaining competitive advantage. In parallel, the regulatory scrutiny accompanying tariff policy is encouraging transparency in sourcing and compliance, further increasing the administrative burden on smaller suppliers and creating consolidation pressures across the distribution channel.

Segment-focused insights revealing how product type, species physiology, application intent, formulation constraints, and distribution strategy determine development pathways

Insightful segmentation analysis reveals differentiated demand drivers and product development priorities across product type, animal type, application, formulation, and distribution channel segments. Based on Product Type, the market is studied across Enzymes, Organic Acids, Phytogenics, Prebiotics, and Probiotics, with Enzymes further studied across Phytase, Protease, and Xylanase and Probiotics further delineated into Bacterial Probiotics and Yeast Probiotics; this delineation highlights the need for formulation science that aligns catalytic activity, pH tolerance, and microbial compatibility with target feed matrices. Based on Animal Type, the market is studied across Aquaculture, Companion Animals, Poultry, Ruminants, and Swine, with Aquaculture further studied across Fish and Shrimp, Companion Animals across Cat and Dog, Poultry across Broiler, Layer, and Turkey, Ruminants across Beef Cattle, Dairy Cattle, and Sheep And Goat, and Swine across Breeder, Grower Finisher, and Sow And Piglet; these distinctions underscore species- and lifecycle-specific gut physiology that dictates different dosing strategies, carrier systems, and evidence thresholds for efficacy.

Based on Application, the market is studied across Feed Additive, Nutritional Supplement, and Therapeutic, which implies divergent regulatory pathways, claims substantiation demands, and commercial channels for adoption, while Based on Formulation, the market is studied across Liquid, Pellet, and Powder, indicating formulation constraints related to stability, heat tolerance, and on-farm handling. Finally, Based on Distribution Channel, the market is studied across Offline and Online, with Offline further studied across Direct Sales and Distributor, reflecting evolving go-to-market strategies where direct-to-producer models coexist with distributor networks and digital commerce. Collectively, these segmentation lenses reveal that product development, regulatory strategy, and commercial execution must be tightly aligned to species-specific biology, application intent, and preferred delivery format to accelerate adoption and demonstrate measurable outcomes.

Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, regulatory strategy, and commercialization

Regional differentiation is a decisive factor for supply strategies, regulatory compliance, and on-farm adoption, with distinct dynamics in the Americas, Europe, Middle East & Africa, and Asia-Pacific shaping commercial opportunity and risk. In the Americas, demand drivers are shaped by large-scale commercial poultry and swine operations that prioritize feed conversion and antimicrobial stewardship, prompting rapid adoption of enzyme and probiotic-based interventions that integrate with precision feeding platforms. In Europe, Middle East & Africa, regulatory frameworks and consumer expectations emphasize antibiotic reduction and traceability, which fuels demand for rigorously validated, documentation-ready solutions and encourages partnerships between ingredient innovators and local formulators.

In Asia-Pacific, intensive aquaculture and mixed-species production present both scale and complexity, driving demand for tailored enzyme blends, robust acidifiers, and locally relevant probiotic strains, while online distribution and contract manufacturing models enable rapid scaling. Across regions, the interplay between regional raw material availability, divergent regulatory regimes, and distribution infrastructure necessitates adaptive market entry strategies that balance local partnerships, regulatory intelligence, and formulation flexibility. Consequently, companies that develop region-specific evidence packages and operational models are better positioned to capture cross-border growth while mitigating trade and compliance risks.

Competitive company strategies centered on proprietary science, scalable manufacturing, and integrated service models to secure differentiation and margin

Competitive dynamics are increasingly influenced by the ability to combine scientific credibility with scalable manufacturing and regulatory competence. Key companies are investing in strain characterization, patent-protected enzyme technologies, and multi-site stability studies to substantiate product claims across species and formulations. In addition to product innovation, successful firms are differentiating through supply chain investments such as localized production, contract manufacturing partnerships, and enhanced cold-chain logistics for sensitive biologicals. These capabilities reduce time to market and provide a competitive moat against commodity pricing pressures.

Furthermore, strategic partnerships between ingredient innovators, feed formulators, and service providers are becoming more common, enabling bundled offerings that pair actives with dosers, diagnostics, and on-farm training. This ecosystem approach increases switching costs for end users and creates opportunities for value-added services that extend beyond the point of sale. For leadership teams, the takeaway is clear: scaling R&D, ensuring regulatory readiness across target markets, and embedding distribution and technical service within commercial models are essential to sustain growth and defend margin in a rapidly professionalizing market.

Actionable strategic priorities for leaders to convert scientific innovation into resilient supply chains, validated formulations, and regionally tailored commercial models

Industry leaders should prioritize a set of actionable initiatives to convert scientific promise into commercial outcomes. First, align R&D roadmaps with species-specific evidence generation that addresses on-farm endpoints such as feed efficiency, morbidity reduction, and resilience under variable environmental conditions. Second, invest in formulation and delivery technologies that protect biological actives across processing and storage environments, enabling broader distribution and lower product loss. Third, pursue supply chain resilience through dual-sourcing, regional manufacturing, and strategic inventory positioning to mitigate tariff and logistics disruption risks.

In parallel, commercial teams should develop regionally tailored value propositions that reflect local regulatory expectations and buyer purchasing patterns, including digital channels for technical education and sales conversion. Executives should also consider strategic partnerships that combine diagnostic capabilities with product bundles to demonstrate measurable outcomes and create recurring-service revenue. Finally, establish cross-functional commercialization sprints that rapidly translate trial results into label claims, marketing assets, and distributor training, thereby shortening the adoption curve and improving return on innovation investment.

Methodological framework combining primary interviews, literature synthesis, on-farm validation, and scenario-based supply chain stress testing for actionable findings

The research methodology synthesizes primary interviews, secondary literature review, and cross-functional validation workshops to ensure findings are robust, replicable, and relevant to commercial decision-making. Primary inputs include structured interviews with R&D leaders, procurement specialists, and commercial managers across feed manufacturers, ingredient suppliers, and large producers, complemented by on-farm case studies that validate product performance under production conditions. Secondary inputs are drawn from peer-reviewed journals, regulatory publications, and industry conference proceedings to ground analysis in current scientific consensus and policy trends.

Analytical approaches include comparative formulation analysis, supply chain stress testing under alternative tariff and logistics scenarios, and segmentation mapping that links product attributes to species-specific physiological requirements and application intents. Findings were triangulated through expert workshops and sensitivity checks to ensure practical relevance. Wherever possible, methodological transparency was maintained by documenting data sources, interview protocols, and assumptions used in constructing scenario analyses and strategic recommendations.

Concluding synthesis that positions intestinal health as a systems-level strategic priority requiring evidence, resilience, and regionally tailored commercialization

In conclusion, intestinal health is an increasingly strategic domain that intersects science, regulation, supply chain, and commercial execution. The convergence of microbiome research, regulatory shifts away from antibiotics, and the advent of more robust formulation and delivery technologies has expanded the toolkit available to producers and formulators. At the same time, trade dynamics and tariff developments in 2025 have underscored the importance of supply chain agility and regional manufacturing capabilities. To win in this environment, companies must integrate rigorous evidence generation with resilient sourcing strategies and region-specific go-to-market models.

Looking ahead, the organizations that will succeed are those that treat intestinal health as a systems-level challenge rather than a discrete product category. By investing in species-specific efficacy studies, formulation science, and operational resilience, stakeholders can translate technical innovations into commercial advantage while meeting evolving regulatory and consumer expectations. The recommended path forward emphasizes cross-functional collaboration, regional adaptation, and measurable outcome orientation to sustainably capture the value inherent in healthier animals and more efficient production systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Increasing adoption of precision probiotics tailored to specific livestock gut microbiomes
• 5.2. Regulatory harmonization of feed additive approvals driving growth in animal gut health solutions
• 5.3. Rising demand for antibiotic alternatives in postweaning pig diets to improve intestinal health
• 5.4. Utilization of next generation sequencing data to inform customized animal microbiome interventions
• 5.5. Emergence of postbiotic feed supplements targeting inflammatory pathways in poultry gut health management
• 5.6. Integration of artificial intelligence in developing precision nutrition strategies for livestock intestinal health

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Intestinal Health Market, by Product Type

• 8.1. Enzymes
  • 8.1.1. Phytase
  • 8.1.2. Protease
  • 8.1.3. Xylanase
• 8.2. Organic Acids
• 8.3. Phytogenics
• 8.4. Prebiotics
• 8.5. Probiotics
  • 8.5.1. Bacterial Probiotics
  • 8.5.2. Yeast Probiotics

9. Animal Intestinal Health Market, by Animal Type

• 9.1. Aquaculture
  • 9.1.1. Fish
  • 9.1.2. Shrimp
• 9.2. Companion Animals
  • 9.2.1. Cat
  • 9.2.2. Dog
• 9.3. Poultry
  • 9.3.1. Broiler
  • 9.3.2. Layer
  • 9.3.3. Turkey
• 9.4. Ruminants
  • 9.4.1. Beef Cattle
  • 9.4.2. Dairy Cattle
  • 9.4.3. Sheep And Goat
• 9.5. Swine
  • 9.5.1. Breeder
  • 9.5.2. Grower Finisher
  • 9.5.3. Sow And Piglet

10. Animal Intestinal Health Market, by Application

• 10.1. Feed Additive
• 10.2. Nutritional Supplement
• 10.3. Therapeutic

11. Animal Intestinal Health Market, by Formulation

• 11.1. Liquid
• 11.2. Pellet
• 11.3. Powder

12. Animal Intestinal Health Market, by Distribution Channel

• 12.1. Offline
  • 12.1.1. Direct Sales
  • 12.1.2. Distributor
• 12.2. Online

13. Animal Intestinal Health Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Animal Intestinal Health Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Animal Intestinal Health Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Cargill, Incorporated
  • 16.3.2. Archer Daniels Midland Company
  • 16.3.3. Koninklijke DSM N.V.
  • 16.3.4. International Flavors & Fragrances Inc.
  • 16.3.5. BASF SE
  • 16.3.6. Evonik Industries AG
  • 16.3.7. Kemin Industries, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. ANIMAL INTESTINAL HEALTH MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. ANIMAL INTESTINAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ANIMAL INTESTINAL HEALTH MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 257. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 260. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 261. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 262. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 263. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 264. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 265. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
• TABLE 266. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
• TABLE 267. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
• TABLE 268. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
• TABLE 269. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 270. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 271. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
• TABLE 272. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2025-2032 (USD MILLION)
• TABLE 273. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
• TABLE 274. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
• TABLE 275. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
• TABLE 276. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
• TABLE 277. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
• TABLE 278. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2025-2032 (USD MILLION)
• TABLE 279. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
• TABLE 280. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2025-2032 (USD MILLION)
• TABLE 281. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 282. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 283. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
• TABLE 284. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
• TABLE 285. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 286. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 287. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
• TABLE 288. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
• TABLE 289. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 290. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 291. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 292. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 293. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
• TABLE 294. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
• TABLE 295. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
• TABLE 296. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
• TABLE 297. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 298. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 299. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
• TABLE 300. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2025-2032 (USD MILLION)
• TABLE 301. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
• TABLE 302. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
• TABLE 303. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
• TABLE 304. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
• TABLE 305. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
• TABLE 306. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2025-2032 (USD MILLION)
• TABLE 307. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
• TABLE 308. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2025-2032 (USD MILLION)
• TABLE 309. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 310. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 311. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
• TABLE 312. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
• TABLE 313. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 314. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 315. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
• TABLE 316. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
• TABLE 317. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 318. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 319. LATIN AMERICA ANIMAL INTESTINAL